Evidence map›Paper›PMID 31428685›Full record

ArticleOpen medicine (Warsaw, Poland)2019

Colorectal Cancer in the Elderly Patient: The Role of Neo-adjuvant Therapy.

Concetta Anna Dodaro, Armando Calogero, Vincenzo Tammaro, Tommaso Pellegrino, Ruggero Lionetti, Silvia Campanile, Marsela Menkulazi, Massimo Ciccozzi, Anna Maria Iannicelli, Francesco Giallauria and 1 more

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Concetta Anna DodaroDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Armando CalogeroDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Vincenzo TammaroDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Tommaso PellegrinoDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Ruggero LionettiDepartment of Public Health, University of Naples Federico II, Naples, Italy.
Silvia CampanileDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Marsela MenkulaziDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Massimo CiccozziMedical Statistics and Molecular Epidemiology Unit, Campus Bio-Medico University, Rome, Italy.
Anna Maria IannicelliDepartment of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.
Francesco GiallauriaDepartment of Translational Medical Sciences, University of Naples "Federico II", Naples, Italy.
Caterina SagnelliDepartment of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
University of Naples Federico II · ITUniversità Campus Bio-Medico · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeoadjuvant chemoradiotherapy has a significant role in downstaging cancer. It improves the local control of the disease and can make conservative resection of rectal cancer possible.

methodsWe enrolled 114 patients with subperitoneal rectal cancer who underwent neoadjuvant chemoradio-therapy and radical excision with total mesorectal excision (TME). The primary endpoint was oncological outcomes and the secondary endpoint was surgical outcomes.We evaluate the experience of a multidisciplinary team and the role of neoadjuvant chemoradiotherapy in integrated treatment of cancer of the subperitoneal rectum.

resultsSurgical procedures performed were abdominal perineal resection in 4 cases (3.5%), anterior resection in 89 cases (78%), Hartmann's procedure in 5 cases (4.4%), and ultralow resection with coloanal anastomosis and diverting stoma in 16 patients (14%).Local recurrence occurred in 6 patients (5.2%), the overall survival was 71.9% at 5 years and disease-free survival was about 60%.

conclusionsThe effect of pathological downstaging amounted to 58.8%, including cPR. The pathologic complete remission occurred in 8.8% of cases.The outcomes of neoadjuvant therapy can be achieved when this treatment is associated with correct surgical technique with TME and the prognosis is defined by an anatomopathological examination performed according to Quirke's protocol.

Indexed as

Colorectal tumorsNeoadjuvant chemoradiotherapyRectal cancer

Identifiers

PMID31428685
PMCPMC6698051
OpenAlexW2967173089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.